In addition to CXCL12, other soluble factors may influence cell adhesion, survival and chemotherapy resistance in AML, potentially inflammatory cytokines through activation of NF-κB pathway as it is the case in other types of cancer (Hoesel and Schmid, 2013). This evidence concerns the gene CXCL12 and acute myeloid leukemia.